How Did The PhaseBio (PHAS) Stock Surge In The Pre-Hours Session, Jumping 21%?
Following the disclosure of its bankruptcy filing, shares of PhaseBio Pharmaceuticals Inc. (NASD: PHAS) were up 21.29% to trade at $0.1709 in pre-market at the last check. What was shared by PHAS? PhaseBio (PHAS) declared yesterday that the company had decided to voluntarily file a petition in the U.S. Bankruptcy Court for the District of […]
